Clinical Trial Update: Selinexor and Backbone Treatments of Multiple Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating selinexor with backbone therapies for multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Karyopharm Therapeutics Inc | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING